New Jersey · 2026-2027 Regular Session
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (2026-01-13)
See how S 2036 affects you on CapitolKey
Browse more bills · CapitolKey home